Science & Research

Regulatory Science Extramural Research and Development Projects

Photos depict FDA regulatory science priority areas

Extramural Research Funded Through the Broad Agency Announcement (BAA)

To spur innovation in the field of regulatory science FDA funds extramural research using various contract mechanisms and grants to address broad Agency challenges within FDA's scientific priority areas.  

Since 2012, FDA has been soliciting proposals to advance the state of the art within these areas through a specialized contract mechanism known as the Broad Agency Announcement (BAA)disclaimer icon. The BAA enables FDA to solicit innovative ideas and approaches to developing and evaluating our regulated products by tapping into external knowledge and infrastructure in areas where FDA has limited expertise or capacities.  The proposals solicited from industry, academia, and other government agencies enable FDA to better understand the breath of innovative scientific and technical solutions available to solve difficult regulatory science problems. 

Descriptions of BAA-funded research projects, their goals, and how they're addressing regulatory science challenges within FDA's scientific priority areas are found below.

Page Last Updated: 03/11/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English